UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4552-4564

2022

Volltextzugriff (PDF)

Absorption, distribution, metabolism and excretion of molidustat in healthy participants

Basic & clinical pharmacology & toxicology, 2020-09, Vol.127 (3), p.221-233

2020

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers

Clinical pharmacology in drug development, 2019-05, Vol.8 (4), p.467-479

2019

Volltextzugriff (PDF)

Application of accelerated solvent extraction followed by gas chromatography, high-performance liquid chromatography and gas chromatography–mass spectrometry for the determination of polycyclic aromatic hydrocarbons, chlorinated pesticides and polychlorinated dibenzo- p-dioxins and dibenzofurans in solid wastes

Journal of Chromatography A, 1997-07, Vol.774 (1), p.203-211

1997

Volltextzugriff (PDF)

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers

Clinical pharmacokinetics, 2005-01, Vol.44 (9), p.969-976

2005

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of the α2C‐Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Clinical pharmacology in drug development, 2022-03, Vol.11 (3), p.296-308

2022

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of the α 2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Clinical pharmacology in drug development, 2022-03, Vol.11 (3), p.296-308

2022

Volltextzugriff (PDF)

Mass spectrometric characterization of the hypoxia‐inducible factor (HIF) stabilizer drug candidate BAY 85‐3934 (molidustat) and its glucuronidated metabolite BAY‐348, and their implementation into routine doping controls

Drug testing and analysis, 2017-01, Vol.9 (1), p.61-67

2017

Volltextzugriff (PDF)

Front Cover: Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia (ChemMedChem 10/2018)

ChemMedChem, 2018-05, Vol.13 (10), p.981-981

2018

Volltextzugriff (PDF)

Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58–2667 in anesthetized dogs

BMC pharmacology, 2007-07, Vol.7 (S1), p.P28-P28, Article P28

2007

Volltextzugriff (PDF)

Chlorobenzenes and hexachlorocyclohexanes (HCHs) in the atmosphere of Bitterfeld and Leipzig (Germany)

Chemosphere (Oxford), 2000-09, Vol.41 (6), p.849-855

2000

Volltextzugriff (PDF)

Identification and Quantification of Thiaarenes in the Flue Gas of Lignite-Fired Domestic Heating

Journal of high resolution chromatography, 2000-08, Vol.23 (7-8), p.457-473

2000

Volltextzugriff (PDF)

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494

2019

Volltextzugriff (PDF)

Incidence of synchronous and metachronous peritoneal metastases for gallblader cancer: A single-center cohort analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16191-e16191

2023

Volltextzugriff (PDF)

Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16199-e16199

2023

Volltextzugriff (PDF)

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment

Palliative care and social practice, 2024-01, Vol.18, p.26323524241260424

2024

Volltextzugriff (PDF)

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4033-4033

2015

Volltextzugriff (PDF)

Acute hypokalemic tetraparesis induced by intravenous methotrexate

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1896-1897

2003

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

Absorption, distribution, metabolism and excretion of molidustat in healthy participants

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers

Pharmacokinetics, Safety, and Tolerability of the α2C‐Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Pharmacokinetics, Safety, and Tolerability of the α 2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Mass spectrometric characterization of the hypoxia‐inducible factor (HIF) stabilizer drug candidate BAY 85‐3934 (molidustat) and its glucuronidated metabolite BAY‐348, and their implementation into routine doping controls

Front Cover: Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia (ChemMedChem 10/2018)

Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58–2667 in anesthetized dogs

Chlorobenzenes and hexachlorocyclohexanes (HCHs) in the atmosphere of Bitterfeld and Leipzig (Germany)

Identification and Quantification of Thiaarenes in the Flue Gas of Lignite-Fired Domestic Heating

Incidence of synchronous and metachronous peritoneal metastases for gallblader cancer: A single-center cohort analysis

Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie)

Acute hypokalemic tetraparesis induced by intravenous methotrexate

Aktive Filter

Suchergebnisse filtern